| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1792 |
| 1 | ETANERCEPT | 1742 |
| 2 | METHOTREXATE | 1647 |
| 3 | ABATACEPT | 1499 |
| 4 | ADALIMUMAB | 1435 |
| 5 | TOCILIZUMAB | 1376 |
| 6 | LEFLUNOMIDE | 1318 |
| 7 | HYDROXYCHLOROQUINE SULFATE | 1192 |
| 8 | SULFASALAZINE | 1069 |
| 9 | TOFACITINIB | 1048 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 39 | 0.1494 |
| 1 | GOLD | 241 | 0.0424 |
| 2 | CHLOROXYLENOL 0.3% | 1 | 0.0345 |
| 3 | ANAKINRA | 423 | 0.0262 |
| 4 | NAPROXEN SODIUM 220MG | 305 | 0.0231 |
| 5 | DESOXIMETASONE | 360 | 0.0194 |
| 6 | PENICILLAMINE | 15 | 0.0163 |
| 7 | SULFASALAZINE | 1069 | 0.0139 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 1192 | 0.0133 |
| 9 | LEFLUNOMIDE | 1318 | 0.0128 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1862 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 1647 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 1499 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 1378 |
| 4 | Antirheumatic Agent [EPC] | 1333 |
| 5 | Corticosteroid [EPC] | 1133 |
| 6 | Aminosalicylate [EPC] | 1084 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 851 |
| 8 | Vitamin B12 [EPC] | 751 |
| 9 | Vitamin C [EPC] | 749 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 423 | 0.0262 |
| 1 | Antirheumatic Agent [EPC] | 1333 | 0.0129 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 1499 | 0.0111 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 1378 | 0.0104 |
| 4 | Aminosalicylate [EPC] | 1084 | 0.0083 |
| 5 | Human Immunoglobulin G [EPC] | 100 | 0.0050 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 1647 | 0.0038 |
| 7 | Vitamin D [EPC] | 747 | 0.0025 |
| 8 | Purine Antimetabolite [EPC] | 227 | 0.0024 |
| 9 | Vitamin B12 [EPC] | 751 | 0.0024 |